Overexpression of E2F‐1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo

J Fueyo, C Gomez-Manzano, WKA Yung, TJ Liu… - Nature medicine, 1998 - nature.com
J Fueyo, C Gomez-Manzano, WKA Yung, TJ Liu, R Alemany, TJ McDonnell, X Shi, JS Rao…
Nature medicine, 1998nature.com
The transfer of apoptosis genes to tumors is one of the most promising strategies for cancer
gene therapy. We have shown that massive apoptosis occurs when wild-type p53
expression is induced in glioma cells carrying a p53 gene mutation. However, adenovirus-
mediated p53 gene transfer is ineffective in causing apoptosis in glioma cells that retain a
wild-type p53 genotype. We evaluated the effect of E2F-1 overexpression on the growth of
gliomas in vitro and in vivo. In the in vitro study, the adenovirus-mediated transfer of …
Abstract
The transfer of apoptosis genes to tumors is one of the most promising strategies for cancer gene therapy. We have shown that massive apoptosis occurs when wild-type p53 expression is induced in glioma cells carrying a p53 gene mutation. However, adenovirus-mediated p53 gene transfer is ineffective in causing apoptosis in glioma cells that retain a wild-type p53 genotype. We evaluated the effect of E2F-1 overexpression on the growth of gliomas in vitro and in vivo. In the in vitro study, the adenovirus-mediated transfer of exogenous E2F-1 protein precipitated generalized apoptosis in gliomas. The treatment with AdSCMV-f 2F-1 of nude mice carrying subcutaneous gliomas arrested tumor growth. Our results indicate that E2F-T has anti-glioma activity in vitro and in vivo.
nature.com